CBT

Cabot Corporation NYSE

Basic Materials ·Chemicals - Specialty ·US · cabotcorp.com

$75.85

Mkt Cap $4.0B

52w Low $58.33 69.0% of range 52w High $83.71

50d MA $73.63 200d MA $72.43

P/E (TTM) 12.7x

EV/EBITDA 6.3x

P/B 2.4x

Debt/Equity 0.8x

ROE 19.8%

P/FCF 10.4x

RSI (14) —

ATR (14) —

Beta 0.83

50d MA $73.63

200d MA $72.43

Avg Volume 446.9K

About

Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 3, 2026	AMC	1.40	1.53	+9.3%	71.29	+5.0%	+10.4%	+7.0%	+4.6%	+4.6%	+6.3%	+3.8%	—
Nov 3, 2025	AMC	1.68	1.70	+1.2%	65.90	-2.8%	-7.1%	-8.2%	-10.0%	-6.7%	-7.3%	-2.1%	—
Aug 4, 2025	AMC	1.82	1.90	+4.4%	73.71	+4.3%	+8.7%	+5.6%	+5.5%	+5.8%	+2.8%	+9.1%	—
May 5, 2025	AMC	1.85	1.90	+2.7%	77.50	-5.2%	-6.5%	-5.8%	-4.1%	-4.6%	-1.8%	-3.1%	—
Feb 3, 2025	AMC	1.74	1.76	+1.1%	84.87	+0.9%	+3.9%	+2.8%	+3.5%	+1.6%	+1.7%	-2.3%	—
Nov 4, 2024	AMC	1.82	1.80	-1.1%	110.09	-2.2%	-1.1%	+6.3%	+5.9%	+4.5%	+5.8%	-2.3%	—
Aug 5, 2024	AMC	1.72	1.92	+11.6%	86.96	+9.1%	+16.4%	+11.1%	+11.8%	+10.6%	+9.5%	+16.4%	—
May 6, 2024	AMC	1.66	1.78	+7.2%	95.94	+4.7%	+5.3%	+5.3%	+6.1%	+6.2%	+6.5%	+2.6%	—
Feb 5, 2024	AMC	1.50	1.56	+4.0%	71.14	+0.9%	+7.9%	+9.1%	+12.6%	+12.2%	+15.0%	+20.6%	—
Nov 6, 2023	AMC	1.48	1.65	+11.5%	66.28	+8.3%	+8.3%	+7.6%	+9.4%	+12.3%	+11.8%	+16.3%	—
Aug 7, 2023	AMC	1.50	1.42	-5.3%	69.34	-6.5%	+1.8%	+1.4%	+2.6%	+3.1%	+2.9%	+4.4%	—
May 8, 2023	AMC	1.31	1.33	+1.5%	70.55	-2.4%	-3.5%	-2.4%	-2.3%	-2.0%	-1.8%	+7.4%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 5	UBS	Maintains	Neutral → Neutral	—	$78.73	$77.91	-1.0%	-3.1%	-5.3%	-5.3%	-3.8%	-3.6%
Feb 5	Mizuho	Downgrade	Outperform → Neutral	—	$78.73	$77.91	-1.0%	-3.1%	-5.3%	-5.3%	-3.8%	-3.6%
Jan 12	UBS	Maintains	Neutral → Neutral	—	$72.83	$72.85	+0.0%	+0.3%	-1.6%	-0.1%	+1.0%	-2.6%
Dec 18	Mizuho	Maintains	Outperform → Outperform	—	$67.53	$68.05	+0.8%	-0.2%	-2.1%	-2.7%	-3.1%	-2.1%
Nov 28	JP Morgan	Maintains	Underweight → Underweight	—	$63.80	$63.02	-1.2%	-1.9%	-0.8%	+0.2%	+1.2%	+0.5%
Nov 17	Mizuho	Maintains	Outperform → Outperform	—	$61.60	$61.54	-0.1%	-3.5%	-2.2%	-3.0%	-4.7%	+0.2%
Nov 5	UBS	Maintains	Neutral → Neutral	—	$61.24	$61.35	+0.2%	-1.3%	-3.1%	+0.4%	-0.2%	+0.3%
Oct 3	Mizuho	Maintains	Outperform → Outperform	—	$75.60	$75.34	-0.3%	-0.6%	-0.1%	-2.9%	-3.4%	-5.8%
Aug 5	UBS	Maintains	Neutral → Neutral	—	$73.71	$76.89	+4.3%	+8.7%	+5.6%	+5.5%	+5.8%	+2.8%
Apr 7	UBS	Maintains	Neutral → Neutral	—	$78.27	$75.99	-2.9%	-2.4%	-4.4%	+3.3%	-1.2%	+1.5%
Feb 21	JP Morgan	Maintains	Underweight → Underweight	—	$85.51	$86.25	+0.9%	-1.2%	-0.7%	+1.7%	+1.3%	-0.1%
Jan 7	Mizuho	Maintains	Outperform → Outperform	—	$88.73	$88.53	-0.2%	-0.0%	-1.2%	-2.3%	+0.7%	+0.7%
Nov 11	JP Morgan	Downgrade	Neutral → Underweight	—	$114.99	$114.58	-0.4%	+1.3%	-2.1%	-3.5%	-5.1%	-5.4%
Nov 5	Mizuho	Maintains	Outperform → Outperform	—	$110.09	$107.67	-2.2%	-1.1%	+6.3%	+5.9%	+4.5%	+5.8%
Aug 7	JP Morgan	Maintains	Neutral → Neutral	—	$101.20	$102.89	+1.7%	-4.5%	-3.9%	-5.0%	-5.9%	-6.1%
Aug 6	UBS	Maintains	Neutral → Neutral	—	$86.96	$94.85	+9.1%	+16.4%	+11.1%	+11.8%	+10.6%	+9.5%
May 7	Mizuho	Maintains	Buy → Buy	—	$95.94	$100.48	+4.7%	+5.3%	+5.3%	+6.1%	+6.2%	+6.5%
May 7	UBS	Maintains	Neutral → Neutral	—	$95.94	$100.48	+4.7%	+5.3%	+5.3%	+6.1%	+6.2%	+6.5%
Apr 18	Deutsche Bank	Downgrade	Buy → Hold	—	$91.93	$91.19	-0.8%	-1.3%	+0.1%	+0.9%	+1.6%	+1.6%
Jan 8	UBS	Downgrade	Buy → Neutral	—	$77.51	$76.35	-1.5%	-0.3%	-1.9%	-0.9%	-1.8%	-1.6%
Dec 14	UBS	Maintains	Buy → Buy	—	$79.91	$80.80	+1.1%	+2.3%	+2.2%	+3.3%	+5.3%	+4.6%
Nov 7	UBS	Maintains	Buy → Buy	—	$66.28	$71.77	+8.3%	+8.3%	+7.6%	+9.4%	+12.3%	+11.8%
Aug 11	JP Morgan	Maintains	Neutral → Neutral	—	$71.12	$70.95	-0.2%	+0.5%	+0.3%	-2.0%	-3.7%	-2.0%
Aug 8	Credit Suisse	Maintains	Outperform → Outperform	—	$69.34	$64.85	-6.5%	+1.8%	+1.4%	+2.6%	+3.1%	+2.9%
Jun 20	Loop Capital	Maintains	Buy → Buy	—	$68.55	$68.06	-0.7%	-2.6%	-3.1%	-4.2%	-6.8%	-5.8%
Jun 6	JP Morgan	Downgrade	Overweight → Neutral	—	$73.69	$69.98	-5.0%	-0.0%	+2.8%	+1.3%	-0.4%	-0.4%
May 18	Deutsche Bank	Maintains	Buy → Buy	—	$69.06	$68.94	-0.2%	+1.7%	+2.7%	+4.6%	+3.2%	+1.4%
May 9	Credit Suisse	Maintains	Outperform → Outperform	—	$70.55	$68.88	-2.4%	-3.5%	-2.4%	-2.3%	-2.0%	-1.8%
Mar 13	Credit Suisse	Maintains	Outperform → Outperform	—	$74.31	$72.97	-1.8%	-1.0%	+2.0%	-2.3%	-0.2%	-3.4%
Feb 13	Loop Capital	Maintains	Buy → Buy	—	$74.03	$75.99	+2.6%	+6.4%	+6.1%	+7.0%	+7.7%	+8.0%
Feb 13	JP Morgan	Maintains	Overweight → Overweight	—	$74.03	$75.99	+2.6%	+6.4%	+6.1%	+7.0%	+7.7%	+8.0%
Nov 16	Deutsche Bank	Upgrade	Hold → Buy	—	$72.75	$73.64	+1.2%	-1.7%	-2.9%	-0.7%	-1.7%	+1.3%
May 17	Deutsche Bank	Maintains	Hold → Hold	—	$68.81	$70.39	+2.3%	+5.0%	+2.6%	+1.4%	+0.6%	+1.8%
Jan 4	UBS	Maintains	Buy → Buy	—	$57.10	$57.18	+0.1%	+2.4%	+1.5%	+1.6%	+2.5%	+1.9%
Dec 3	Barclays	Maintains	Overweight → Overweight	—	$53.48	$53.71	+0.4%	+3.7%	+4.7%	+4.8%	+5.5%	+4.3%
Jul 23	JP Morgan	Upgrade	Neutral → Overweight	—	$51.79	$53.68	+3.6%	+3.4%	+4.6%	+3.5%	+4.2%	+6.3%
Jul 1	Loop Capital	Upgrade	Hold → Buy	—	$56.93	$58.89	+3.4%	+2.4%	+1.7%	+0.3%	+2.2%	-0.5%
May 5	Northcoast Research	Upgrade	Neutral → Buy	—	$57.40	$58.70	+2.3%	+6.1%	+9.6%	+8.7%	+7.2%	+7.3%
Nov 5	UBS	Maintains	Buy → Buy	—	$38.66	$39.28	+1.6%	+6.9%	+6.6%	+11.0%	+11.7%	+7.5%
Jul 27	JP Morgan	Downgrade	Overweight → Neutral	—	$38.25	$37.20	-2.7%	+1.4%	-1.6%	+1.0%	-3.1%	-4.6%
Jun 19	UBS	Maintains	Buy → Buy	—	$37.31	$38.06	+2.0%	-0.4%	-1.7%	-0.7%	-4.4%	-2.5%
May 12	UBS	Maintains	Buy → Buy	—	$31.84	$31.54	-0.9%	-7.4%	-11.5%	-9.7%	-8.6%	+2.9%
Apr 16	Deutsche Bank	Maintains	Hold → Hold	—	$29.10	$28.94	-0.5%	-2.8%	+2.4%	+0.1%	-2.2%	+0.5%
Apr 3	JP Morgan	Upgrade	Neutral → Overweight	—	$25.96	$27.80	+7.1%	+0.0%	+7.6%	+7.4%	+12.6%	+18.0%
Mar 31	SunTrust Robinson Humphrey	Maintains	Buy → Buy	—	$26.25	$26.01	-0.9%	-0.5%	+0.9%	-1.1%	-1.1%	+6.4%
Mar 23	UBS	Maintains	Buy → Buy	—	$21.08	$21.13	+0.2%	+4.1%	+15.4%	+24.1%	+26.8%	+18.8%
Feb 7	UBS	Upgrade	Neutral → Buy	—	$42.34	$43.67	+3.1%	-1.1%	-1.2%	+1.4%	+3.4%	+1.9%
Nov 6	JP Morgan	Downgrade	Overweight → Neutral	—	$49.93	$49.18	-1.5%	-3.7%	-0.4%	+0.6%	-0.9%	-1.2%
Oct 16	Baird	Downgrade	Outperform → Neutral	—	$43.87	$42.60	-2.9%	-1.4%	-0.1%	-0.2%	+0.2%	+1.3%
Oct 10	UBS	Maintains	Neutral → Neutral	—	$42.71	$42.89	+0.4%	-0.1%	+4.2%	+2.2%	+2.7%	+1.3%

Recent Filings

8-K

Unknown — 8-K Filing

I cannot provide a meaningful analysis as the filing appears to be incomplete technical XBRL metadata without substantive disclosure content regarding CBT's business developments or financial changes.

Mar 17

8-K

Cabot Corporation -- 8-K Filing

Cabot Corporation's Performance Chemicals segment delivered 7% EBIT growth year-over-year in Q1 fiscal 2026, driven by strong momentum in its Battery Materials product line.

Feb 3

Data updated apr 25, 2026 12:09am · Source: massive.com